Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Open Label, Single Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients With Recurrent High-Grade Glioma.

NCT00040573 is registered in ClinicalTrials.gov with TransMolecular as lead sponsor.

NCT NCT00040573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00040573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Open Label, Single Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients With Recurrent High-Grade Glioma.
Lead sponsor
TransMolecular
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2002
Completion date
August 31, 2003
Enrollment
18
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain neoplasm, glioma